Moebius Medical ^{For Profit}

Moebius Medical is a clinical-stage biotech company that focuses on the development of novel products using proprietary liposomal technologies. They were founded in 2008 to commercialize a patent-protected liposomal technology licensed from the Hebrew University of Jerusalem, the Technion Institute and Hadassah Medical Center. Moebius's scientific team has years of experience and leadership in liposome technology, process development, analytics, and CMC. Their lead product, MM-II, is a non-opioid intra-articular injection that provides sustainable relief of symptomatic knee pain in osteoarthritic patients. They are currently recruiting patients for a large clinical trial to be carried out in the US, Denmark, and Hong Kong. For partnering inquiries, they can be contacted through the link on their website. Contact Info: N/A